GlassScriptPhysician profile
Amanda Wiegel
NPI 1003451501
$4,281.78
in general payments reported to CMS, 2019-2025
19 companies · $2,702 in 2025
The $2,702 reported for 2025 was more than what 97% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $134 · 2022: $385 · 2023: $815 · 2024: $245 · 2025: $2,702.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $1,573 · Food and Beverage: $1,532 · Travel and Lodging: $657.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $1,573.34 |
| Food and Beverage | $1,531.53 |
| Travel and Lodging | $657.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $1,573.34 | 2025 | Venacure 1470 Pro |
| Medtronic, INC. | $702.22 | 2025 | Venaseal |
| Abbvie INC. | $428.25 | 2022-2025 | |
| Glaxosmithkline, LLC. | $243.00 | 2021-2023 | Arexvy |
| Genzyme Corporation | $240.54 | 2023-2024 | |
| Jazz Pharmaceuticals INC. | $185.62 | 2022 | |
| Galderma Laboratories, L.P. | $133.64 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $124.80 | 2025 | Zoryve |
| Axsome Therapeutics, INC. | $112.12 | 2025 | Auvelity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $108.13 | 2023 | Jardiance |
| Dexcom, INC. | $105.05 | 2023 | Dexcom G7 Gss (161) |
| Boston Scientific Corporation | $80.49 | 2024-2025 | Varithena Administration Pack |
| Amgen INC. | $77.60 | 2023 | Repatha |
| Biogen, INC. | $61.43 | 2024 | |
| Cardiovascular Systems INC. | $28.90 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $27.58 | 2022-2025 | Flexitouch Plus, Nimbl |
| Cashflow Solutions, LLC | $19.52 | 2024 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
| Merck Sharp & Dohme LLC | $16.96 | 2022 | |
| Resmed Corp | $12.59 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Wiegel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.